About James Cloar
James Cloar is a director at Marrow Access Technologies.
James Cloar first appears on SEC filings in 2024.
Experience
This experience comes from James Cloar's profile and from SEC filings. For roles taken from filings, the years are when the filings name James Cloar in the role, so the role may have started earlier or lasted longer.
AP
Aspen Medical Products Current
Chief Executive Officer
2020 – Present
Marrow Access Technologies, Inc.
Director
2024 – 2026 · Eden Prairie, MN
Marrow access devices for surgeons treating patients with cartilage defects.
ZS
ZimmerBiomet Spine
President (2019 – 2020)
Vice President, Chief Commercial Officer, Spine & Robotics (2018 – 2020)
2018 – 2020
SM
Synaptive Medical
Chief Commercial Officer
2016 – 2017
BI
Biomet
General Manager-Global Spine
2013 – 2015
PT
Pathfinder Therapeutics
President & CEO
2012 – 2013
ME
Medtronic
Vice President/General Manager (2007 – 2011)
Vice President, General Manager, Thoracolumbar Division (1997 – 2007)
1997 – 2011
DO
DePuy Orthopaedics
Territory General Manager
1993 – 1997
SN
Smith & Nephew
Senior Product Manager, Trauma
1990 – 1992
CB
CR Bard
Product Manager, Bard Urological Division
1985 – 1990
Key Colleagues at Startups
The people James Cloar works with at each company, as listed on that company's latest Form D.
Marrow Access Technologies, Inc. · Form D, Apr 9, 2026
JK
Jason Koh
Executive officer and director
PV
Paul Verrastro
Director
DF
Dan Fisher
Director
JS
Joseph Saladino
CEO and director
KF
Kevin Foley
Director